ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 10,287 shares, the number of shares held decreased 0.8% compared to the previous period and now represents 9.2% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 33,800 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.52% of the total position.
      116Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 890 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 3.9% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 11,062 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 3.56% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 26,344 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 0.66% of the total position.
      1.20KComment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 18,620 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 1.35% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 4,054 shares, the number of shares held increased 0.19% compared to the previous period and now represents 2.25% of the total position.
      50Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 4,168 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.51% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 594 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 4.26% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 3,794 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 4.07% of the total position.
      1Comment
      Report
     
     
     
     

    Most Discussed